These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15653666)

  • 1. (68)Ga-labeled peptides in tumor imaging.
    Maecke HR; Hofmann M; Haberkorn U
    J Nucl Med; 2005 Jan; 46 Suppl 1():172S-8S. PubMed ID: 15653666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold Kit Labeling: The Future of
    Lepareur N
    Front Med (Lausanne); 2022; 9():812050. PubMed ID: 35223907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [
    Durieux F; Dekyndt B; Legrand JF; Rogeau A; Malek E; Semah F; Odou P
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of [
    Rodnick ME; Sollert C; Parr DC; Frigell J; Gagnon K; Scott PJH
    Methods Mol Biol; 2024; 2729():55-64. PubMed ID: 38006491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding Role for Gallium-68 PET Imaging in Oncology.
    Kleynhans J; Ebenhan T; Sathekge MM
    Semin Nucl Med; 2024 Jul; ():. PubMed ID: 38964934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron.
    Ashhar Z; Ahmad Fadzil MF; Md Safee Z; Aziz F; Ibarhim UH; Nik Afinde NMF; Mat Ail N; Jamal Harizan MAH; Halib D; Alek Amran A; Adawiyah R; Abd Hamid MHN; Mahamood M; Razali NI; Said MA
    Appl Radiat Isot; 2024 Mar; 205():111161. PubMed ID: 38163386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium-68 PET: a new frontier in receptor cancer imaging.
    Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D
    Anticancer Res; 2007; 27(6B):4087-94. PubMed ID: 18225576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
    Fani M; André JP; Maecke HR
    Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of a key resource - the germanium-68/gallium-68 generator: development and new insights.
    Roesch F
    Curr Radiopharm; 2012 Jul; 5(3):202-11. PubMed ID: 22697481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renaissance of the ⁶⁸Ge/⁶⁸Ga radionuclide generator initiates new developments in ⁶⁸Ga radiopharmaceutical chemistry.
    Roesch F; Riss PJ
    Curr Top Med Chem; 2010; 10(16):1633-68. PubMed ID: 20583984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways.
    Morgat C; Hindié E; Mishra AK; Allard M; Fernandez P
    Cancer Biother Radiopharm; 2013 Mar; 28(2):85-97. PubMed ID: 23461410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-68 -- a new opportunity for PET available from a long shelf-life generator - automation and applications.
    Decristoforo C
    Curr Radiopharm; 2012 Jul; 5(3):212-20. PubMed ID: 22642389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of generator-produced 68Ga for medical application.
    Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
    J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    Antunes P; Ginj M; Zhang H; Waser B; Baum RP; Reubi JC; Maecke H
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):982-93. PubMed ID: 17225119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET.
    Notni J; Pohle K; Wester HJ
    EJNMMI Res; 2012 Jun; 2(1):28. PubMed ID: 22682112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
    Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V
    Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.
    Liu Z; Niu G; Wang F; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.